Will "Drug" be in the headlines this week?

Track live probability, outcome prices, volume, liquidity, and resolution details for Will "Drug" be in the headlines this week?. The market currently shows a live probability of 51%, $10.1 in 24h volume, and $33.1 in liquidity.

Track live world event prediction markets focused on geopolitics, international relations, global conflicts, diplomacy, and major worldwide developments.

This market is currently listed with an end date of Jul 5, 2026. Market timelines can change if the underlying event is postponed, rescheduled, or resolved early.

This market will resolve to “Yes” if the listed term is included in a headline on the New York Times front page between June 29 and July 5, 2026. Otherwise, this market will resolve to “No”. A headline is defined as the bolded or enlarged text directly preceding each article, previewing the article’s content and typically separated from the article’s text by a black line and byline. The primary headline for each story is the headline for that story with the largest text, typically appearing in bold font and above any other headlines or text for that article. Sub-headlines, defined as additional bolded or enlarged text not separated from the primary headline by any text, will count, whether they appear before the byline or are partially surrounded by the article text but still adjacent to the primary headline. Pull quotes, however, or any bolded text not adjacent to the primary headline, will not count. Banner headlines, defined as front-page headlines bordered on the sides only by white space, will count. Image captions, article text, or any other text that does not constitute a headline, will not qualify. Any plural or possessive forms of a listed term, as well as variations in capitalization, will count toward the resolution of this market, regardless of context. Other forms of the listed term will not count. Misspellings or iterations of the listed term, including all slang forms, will not count toward a “Yes” resolution, regardless of context or intent. If the listed term appears as part of a compound word, usage of that compound word qualifies, provided the listed term remains a distinct component of the compound. This does not include suffixes, prefixes, alternative tenses, or grammatical variations that alter the root word. (E.g. if the listed term is joy, killjoy qualifies but joyful does not. E.g. if the listed term is sun, sunflower qualifies but sunny does not.) If the listed term is part of a hyphenated compound, use of that hyphenated compound will qualify. For example, if the listed term is “NATO,” “pro-NATO” and “anti-NATO” qualify. If the listed term has non-standard transliterations into English, such transliterations will qualify if they are phonetically equivalent. For example, if the listed term is “Erdogan,” “Erdoğan” qualifies. If the listed term is “Zelensky,” “Zelenskiy” qualifies. If the listed term is an abbreviation, periodized forms of that abbreviation will qualify. For example, if the listed term is “AI,” “A.I.” qualifies. However, extraneous symbols inserted into a word (e.g. r@d1cal for “radical”) will disqualify it from counting toward a “Yes” resolution. This market only pertains to the daily New York edition prints of the New York Times, also available at https://nytimes.pressreader.com/the-new-york-times/. Only the first official release of a qualifying front page will be counted. Any subsequent releases that differ from the initial release will not be considered. Other editions will not be considered. You can find an example of what counts here: https://polymarket-upload.s3.us-east-2.amazonaws.com/nyt-headlines.jpeg.